Aptorum Group to Be Newly Added to MSCI HK Micro Cap Index
2019年5月22日 - 9:00PM
ビジネスワイヤ(英語)
Aptorum Group Limited (Nasdaq: APM) (“the Company”) a
pharmaceutical company dedicated to developing and commercializing
a broad range of therapeutic and diagnostic technologies to tackle
unmet medical needs, announced today the Company’s addition to the
Morgan Stanley Capital International MSCI (“MSCI”) Hong Kong Micro
Cap Index, effective Tuesday, May 28, 2019, Hong Kong Time.
MSCI Hong Kong Micro Cap Index is an international equity
benchmark recognized by institutional investors. Inclusion of
constituent companies is based on excellence of performance and
potential of development. We believe that our inclusion in the MSCI
Hong Kong Micro Cap Index will help expand Aptorum's investor base
and enhance its corporate image and market presence.
Founder and Chief Executive Officer of Aptorum Group and Mr. Ian
Huen commented “We are honoured to be added as a constituent stock
of the MSCI Hong Kong Micro Cap Index. The inclusion reaffirms
market recognition of Aptorum’s performance in the aspect of
maximizing investors’ return, and we believe, in the near future,
will increase Aptorum’s visibility in the investment market and
elevate Aptorum’s market position.”
About Aptorum Group Limited
Aptorum Group Limited (Nasdaq: APM) is a pharmaceutical company
dedicated to developing and commercializing a broad range of
therapeutic and diagnostic technologies to tackle unmet medical
needs. Aptorum Group is pursuing therapeutic and diagnostic
projects in neurology, infectious diseases, gastroenterology,
oncology and other disease areas as well as non-therapeutic areas
such as surgical robotics and the operations of its medical clinic
in Hong Kong, Talem Medical, with the initial focus on treatment of
chronic diseases resulting from modern sedentary lifestyles and
aging population.
For more information about Aptorum Group, please visit
www.aptorumgroup.com.
Disclaimer and Forward-Looking Statements
This press release includes statements concerning Aptorum
Group Limited and its future expectations, plans and prospects that
constitute “forward-looking statements” within the meaning of the
Private Securities Litigation Reform Act of 1995. For this purpose,
any statements contained herein that are not statements of
historical fact may be deemed to be forward-looking statements. In
some cases, you can identify forward-looking statements by terms
such as “may,” “should,” “expects,” “plans,” “anticipates,”
“could,” “intends,” “target,” “projects,” “contemplates,”
“believes,” “estimates,” “predicts,” “potential,” or “continue,” or
the negative of these terms or other similar
expressions. Aptorum Group has based these forward-looking
statements largely on its current expectations and projections
about future events and trends that it believes may affect its
business, financial condition and results of operations. These
forward-looking statements speak only as of the date of this press
release and are subject to a number of risks, uncertainties and
assumptions including, without limitation, risks related to its
announced management and organizational changes, the continued
service and availability of key personnel, its ability to expand
its product assortments by offering additional products for
additional consumer segments, the company’s anticipated growth
strategies, anticipated trends and challenges in its business, and
its expectations regarding, and the stability of, its supply chain,
and the risks more fully described in Aptorum Group’s Form
20-F and other filings that Aptorum Group may make
with the SEC in the future. Aptorum Group
assumes no obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190522005359/en/
Investors:Tel: +852 2117 6611Email:
investor.relations@aptorumgroup.comMedia:Tel: + 852 2117 6611Email:
info@aptorumgroup.com
Aptorum (NASDAQ:APM)
過去 株価チャート
から 3 2024 まで 4 2024
Aptorum (NASDAQ:APM)
過去 株価チャート
から 4 2023 まで 4 2024